Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.

Fisher, 2011, Candida urinary tract infections—treatment, Clin Infect Dis, 52, S457, 10.1093/cid/cir112

Pappas, 2016, Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America, Clin Infect Dis, 62, e1, 10.1093/cid/civ1194

Cornely, 2012, ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients, Clin Microbiol Infect, 18, 19, 10.1111/1469-0691.12039

Chen, 2011, Echinocandin antifungal drugs in fungal infections: a comparison, Drugs, 71, 11, 10.2165/11585270-000000000-00000

Lewis, 2007, Pharmacodynamic implications for use of antifungal agents, Curr Opin Pharmacol, 7, 491, 10.1016/j.coph.2007.05.004

Kane, 2016, Micafungin in the treatment of candiduria: a case series, Med Mycol Case Rep, 11, 5, 10.1016/j.mmcr.2016.01.003

de la Torre, 2014, Micafungin: an evidence-based review of its place in therapy, Core Evid, 9, 27